Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2431741
Title:
Verfahren zur bestimmung aktiver inhaltssoffe in arzneimittelvorstufen-peg-protein konjugaten mit freisetzbaren peg-regentien (in-vitro-depegylierung)
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
110099199
WO application number:
Type:
European patent granted for BE
Status:
Open
Publication number:
2431741
WO publication number:
1rst applicant's nationality:
Translation language:
German
EPO publication language:
English
SPC number:
Dates
Filing date:
20/10/2009
Grant date:
21/08/2013
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
21/11/2013
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
21/08/2013
EP B1 publication date:
21/08/2013
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
20/10/2029
Applicant
1
Name:
Nektar Therapeutics
Legal Form:
From:
19/05/2017
Address:
455 Mission Bay Boulevard South,
Suite 100, San Francisco, CA 94158, United States (US)
To:
2
Name:
Takeda Pharmaceutical Company Limited
Legal Form:
From:
14/10/2021
Address:
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka, Japan (JP)
To:
3
Name:
Baxter International Inc
Legal Form:
From:
21/08/2013
Address:
One Baxter Parkway, Deerfield IL 60015, United States (US)
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws
2
Bulletin heading:
CO
Journal edition number:
2017/05b
Publication date:
16/09/2019
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders
3
Bulletin heading:
CO
Journal edition number:
2021/22
Publication date:
10/01/2022
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders